Clinical ink Advocates for Greater Industry Focus on Patient User Experience

Patient looking at smartwatch

Chief Innovation Officer to Speak on Importance of Applying User Experience Design Practices at DPHARM tech showcase and Mobile Technology in Clinical Trials Panel

Horsham, Pa.; August 16, 2022Clinical ink, a global life science technology company, will be hosting presentations on the critical importance of incorporating user experience design expertise into clinical study technology at this Fall’s 9th Annual Mobile Technology in Clinical Trials Conference as well as the 12th Annual DPHARM (Disruptive Innovations to Modernize Clinical Research) Conference.

First, at the Mobile Technology in Clinical Trials Conference on September 12, 2022,  Joan Severson, Chief Innovation Officer at Clinical ink, will be in conversation with Adama Ibrahim, of Novo Nordisk, Patient Advocate Tina Aswani-Omprakash, MarieElena Cordisco of Nuvance Health, Timothy Joy of Pfizer, and Ash Rishi of COUCH Health on the topic “Solving for the Digital Divide: Building Trust with Mobile Technologies to Increase Patient Participation in Clinical Trials.” The discussion, beginning at 10:30 am ET, will revolve around breaking down barriers to patient access, as well as how to reduce participation anxiety and reimagine trial design to take advantage of digital modalities that can increase patient satisfaction.

The next day, September 13, 2022 during the DPHARM Conference at 11:35 am, Severson will be presenting on the topic of “Patient Science, Usability, and The Future of Clinical Trials.” The talk will cover the importance of integrating user experience design principles into every virtual study—including in-depth research into patient and condition-specific needs, clinical practice, and technology engineering. Severson will demonstrate how Clinical ink embraces these UX concepts via integrating animation, calibration, and feedback directly into mobile study applications—better ensuring inclusivity and access, as well as a more engaging patient experience.

About Clinical ink

Clinical ink is the global life science company that brings data, technology, and patient science together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, drive the industry standard for data precision and usher in a new generation of clinical trials. By harnessing digital data, we power sponsors, CROs, researchers, and patients to recenter decentralized trials and rewrite the clinical development experience.  

About DPHARM®   

DPHARM (Disruptive Innovations to Modernize Clinical Research) offers an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders unveil the latest innovations to modernize clinical trials. 

About Mobile Tech in Clinical Trials  

The Mobile Tech in Clinical Trials Conference helps R&D operation executives support more patients remotely and to understand where these technologies will and won’t work to ensure full patient support while managing invaluable data collection.

Scroll to Top